Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist

Authors

  • Brian Godman Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, GlasgowG4 0RE, United Kingdom

DOI:

https://doi.org/10.3329/bjms.v20i1.50338

Keywords:

Adalimumab; biosimilars; demand-side measures; generics; insulin glargine; savings

Abstract

Abstract Not Available

Bangladesh Journal of Medical Science Vol.20(1) 2021 p.5-10

Downloads

Download data is not yet available.
Abstract
27
PDF
57

Downloads

Published

2021-01-01

How to Cite

Godman, B. (2021). Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist. Bangladesh Journal of Medical Science, 20(1), 5–10. https://doi.org/10.3329/bjms.v20i1.50338

Issue

Vol. 20 No. 1 (2021)

Section

Editorial

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.